If you’ve heard 7-hydroxymitragynine—also known as 7-OH—referred to as “gas station heroin,” you’re not alone. It’s a phrase designed to provoke fear, not inform. And it couldn’t be further from the truth. The science behind 7-OH tells a very different story—one of a naturally occurring, plant-derived compound that may offer a safer alternative for managing pain and supporting recovery.
A Natural Compound—Not a Synthetic One
7-OH is not a synthetic drug created in a lab. It’s a naturally occurring alkaloid found in very small amounts in the kratom plant (Mitragyna speciosa). More importantly, it’s also produced inside the human body when the primary kratom compound—mitragynine—is metabolized by the liver. Studies show that roughly 21% to 31% of consumed mitragynine is converted into 7-OH, depending on the dose.
So, if you’ve taken kratom, you’ve already experienced 7-OH. The only difference with 7-OH-based products is that they replicate this metabolic conversion externally using natural oxidation—removing variability, increasing consistency, and reducing liver burden.
Why It’s Not Comparable to Heroin
Let’s break down the facts. Heroin is a full opioid agonist, meaning it completely activates opioid receptors in the brain—causing euphoria, sedation, and dangerously suppressed breathing. That’s what makes it so addictive and so deadly.
7-OH is fundamentally different:
It acts as a partial agonist at the mu-opioid receptor, meaning it only partially activates the receptor and cannot reach the same level of effect as full opioids like heroin or fentanyl.
It exhibits a “ceiling effect,” meaning taking more doesn’t increase the effect beyond a certain point. This greatly reduces the risk of overdose.
It does not meaningfully activate the β-arrestin2 pathway, which is the mechanism responsible for life-threatening respiratory depression.
There is no established lethal dose (LD50) for 7-OH, and to date, no confirmed deaths have been linked to 7-OH use alone.
So Where Did the Fear Come From?
The term “gas station heroin” was never born from toxicology data or peer-reviewed research—it came from industry competitors with something to lose. Some kratom lobbying groups have used this term to discredit 7-OH while protecting their own market position. These same groups often promote high-dose mitragynine products, which ironically require the body to metabolize even more 7-OH internally—placing greater stress on the liver in the process.
Rather than working toward shared standards for safety and regulation, some stakeholders have chosen to spread disinformation to eliminate competition. The science tells us this isn’t about public health—it’s about market control.
What the Science (and Real People) Say
Thousands of people across the U.S. are now turning to 7-OH as a life-changing alternative to traditional opioids, alcohol, and prescription medications. In testimonials from patients, veterans, working professionals, and those in recovery, we hear the same themes again and again:
Pain management for conditions like arthritis, migraines, sciatica, and post-surgical pain
Support for mental health, including depression, anxiety, PTSD, and BPD
A tool for recovery, helping people taper off heroin, fentanyl, Suboxone, and alcohol
Improved quality of life, with less sedation, better focus, and fewer side effects
Unlike prescription opioids, 7-OH users report that they can function in daily life without feeling “numbed out” or sedated. Many say they’ve been able to get off stronger substances and stay clean thanks to 7-OH.
Let’s Lead With Facts, Not Fear
The U.S. Department of Health and Human Services has already rejected efforts to ban kratom and its components, citing the public health risks of cutting off access. Scientific advisory groups, former federal drug policy officials, and harm reduction advocates are urging policymakers to pursue regulation—not prohibition.
The bottom line: 7-OH is not heroin. It’s not synthetic. It’s not some untested street drug. It’s a naturally derived compound with a distinct, safer mechanism of action—already helping thousands of people manage pain and addiction without the risks associated with traditional opioids.
"Rather than working toward shared standards for safety and regulation, some stakeholders have chosen to spread disinformation to eliminate competition. The science tells us this isn’t about public health—it’s about market control."
